A week after announcing 2013 revenues of $1.3 million — more than double its 2012 revenues — WaferGen Biosystems this week set a lofty goal of more than $5 million for its top line in 2014
Trovagene said this week that Charles Cantor has joined the company's scientific advisory board.
NEW YORK (GenomeWeb News) – WaferGen Biosystems reported after the close of the market on Thursday a 55 percent jump in its fourth quarter revenues.
This article has been updated with comments from AltheaDx.
WaferGen Biosystems has shuffled and reduced the size of its board of directors to seven from nine following the firm's acquisition of IntegenX's next-g
WaferGen has made changes to its board of directors following the
NEW YORK (GenomeWeb News) — WaferGen Biosystems said today that it has acquired the next-generation sequencing library preparation business of IntegenX.
NEW YORK (GenomeWeb News) – Wafergen Biosystems today said that revenues in its third quarter more than doubled year over year.
Clontech Laboratories has launched its SMARTer Stranded RNA-seq kit for strand-specific RNA-seq from low-input samples.
Fresh off of a $15 million private placement and restructuring transaction intended to simplify its capital structure, WaferGen Biosystems has shifted its focus to position itself as a provider of tools to supplement next-generation sequencing.
Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.
The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.
Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.
In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.